Search Results 1451-1460 of 19477 for Hemoglobin

1. A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers - Mayo Clinic

   Participation eligibility · Hemoglobin ≥ 8 g/dL; · Absolute neutrophil count ≥ 1000/μL; · Platelet count ≥ 75,000/μL (≥ 30,000/μL if bone marrow plasma cells ...

2. Veliparib and Floxuridine in Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, or Fallopian Tube Cancer - Mayo Clinic

   Hemoglobin (Hgb) > 9.0 mg/dl; Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1, or 2; Ability to provide informed written consent; Life ...

3. Mannitol-Based Solutions in the Quantification of Visceral Hypersensitivity - Mayo Clinic

   Presence of documented pseudo-obstruction, diabetes mellitus with a hemoglobin A1c of more than or equal to 8, scleroderma, slow transit constipation and ...

4. A Study of Rucaparib Verses Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency - Mayo Clinic

   Hemoglobin ≥ 10 g/dL independent of transfusion within 14 days. Hepatic Function: Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 3 ...

5. A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14-431 or M14-433 - Mayo Clinic

   Hemoglobin < 8 g/dL. Enrollment in another interventional clinical study while participating in this study. For Substudy 3 only: Total SES-CD > 4 and/or ...

6. A Study to Evaluate TVB-2640 and Trastuzumab Plus Paclitaxel or Endocrine Therapy for Treating Patients with HER2 Positive Advanced Breast Cancer - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL;; Absolute neutrophil count (ANC) ≥ 1500/mm^3; Platelet count; ≥ 100,000/mm^3;; Direct bilirubin ≤ 1.5 x ULN;; Aspartate transaminase ...

7. A Study to Evaluate Abemaciclib to Treat Advanced Bone and Soft Tissue Sarcoma Identified as Having CDK Pathway Alteration - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dL. Patients may receive erythrocyte transfusions to achieve this hemoglobin level at the discretion of the investigator. Initial ...

8. Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma - Mayo Clinic

   Hemoglobin >= 8.0 g/dL; Diagnosis of symptomatic MM; Measurable disease of multiple myeloma at the time of baseline values for disease assessment as defined ...

9. Autologous DC Vaccine For RRP Patients - Mayo Clinic

   Hemoglobin ≥ 8.5 g/dL; Lymphocytes ≥ 0.3 x 109 /L; Total bilirubin ≤ 2 x upper limit of normal (ULN), unless patient has a documented history of Gilbert's ...

10. Phase 1 Study to Evaluate the Safety of ATA188 in Subjects With Progressive and Relapsing-Remitting Multiple Sclerosis - Mayo Clinic

    Hemoglobin < 10 g/dL; platelet < 100×109/L; absolute neutrophil count < 1.5×109/L. Any contraindication to MRI and/or Gd, eg, any object that is reactive to ...